These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26473439)

  • 1. Massive Organ Inflammation in Experimental and in Clinical Meningococcal Septic Shock.
    Hellerud BC; Olstad OK; Nielsen EW; Trøseid AM; Skadberg Ø; Thorgersen EB; Vege Å; Mollnes TE; Brandtzæg P
    Shock; 2015 Nov; 44(5):458-69. PubMed ID: 26473439
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Brusletto BS; Hellerud BC; Øvstebø R; Brandtzaeg P
    Front Cell Infect Microbiol; 2023; 13():1298360. PubMed ID: 38089821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
    Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
    Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive Changes in Transcriptomic "Fingerprints" and Immunological Cells in the Large Organs of Patients Dying of Acute Septic Shock and Multiple Organ Failure Caused by
    Brusletto BS; Løberg EM; Hellerud BC; Goverud IL; Berg JP; Olstad OK; Gopinathan U; Brandtzaeg P; Øvstebø R
    Front Cell Infect Microbiol; 2020; 10():42. PubMed ID: 32154187
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcriptomic changes in the large organs in lethal meningococcal shock are reflected in a porcine shock model.
    Brusletto BS; Hellerud BC; Olstad OK; Øvstebø R; Brandtzaeg P
    Front Cell Infect Microbiol; 2022; 12():908204. PubMed ID: 36034711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 immunodepletion from meningococcal sepsis plasma induces extensive changes in gene expression and cytokine release in stimulated human monocytes.
    Gopinathan U; Brusletto BS; Olstad OK; Kierulf P; Berg JP; Brandtzaeg P; Øvstebø R
    Innate Immun; 2015 May; 21(4):429-49. PubMed ID: 25233959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
    Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
    J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new dynamic porcine model of meningococcal shock.
    Nielsen EW; Hellerud BC; Thorgersen EB; Castellheim A; Pharo A; Lindstad J; Tønnessen TI; Brandtzaeg P; Mollnes TE
    Shock; 2009 Sep; 32(3):302-9. PubMed ID: 19174740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes.
    Brandtzaeg P; Osnes L; Ovstebø R; Joø GB; Westvik AB; Kierulf P
    J Exp Med; 1996 Jul; 184(1):51-60. PubMed ID: 8691149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide.
    Sprong T; Møller AS; Bjerre A; Wedege E; Kierulf P; van der Meer JW; Brandtzaeg P; van Deuren M; Mollnes TE
    Infect Immun; 2004 Jun; 72(6):3344-9. PubMed ID: 15155639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes.
    Gopinathan U; Ovstebø R; Olstad OK; Brusletto B; Dalsbotten Aass HC; Kierulf P; Brandtzaeg P; Berg JP
    Infect Immun; 2012 Nov; 80(11):4046-54. PubMed ID: 22966040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock.
    Bjerre A; Brusletto B; Høiby EA; Kierulf P; Brandtzaeg P
    Crit Care Med; 2004 Feb; 32(2):433-8. PubMed ID: 14758160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification and pathogenesis of meningococcal infections.
    Brandtzaeg P; van Deuren M
    Methods Mol Biol; 2012; 799():21-35. PubMed ID: 21993637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD46 accelerates macrophage-mediated host susceptibility to meningococcal sepsis in a murine model.
    Wang X; Zhang D; Sjölinder M; Wan Y; Sjölinder H
    Eur J Immunol; 2017 Jan; 47(1):119-130. PubMed ID: 27794168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase.
    Pathan N; Franklin JL; Eleftherohorinou H; Wright VJ; Hemingway CA; Waddell SJ; Griffiths M; Dennis JL; Relman DA; Harding SE; Levin M
    Crit Care Med; 2011 Jul; 39(7):1692-711. PubMed ID: 21494108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.
    Derkx B; Marchant A; Goldman M; Bijlmer R; van Deventer S
    J Infect Dis; 1995 Jan; 171(1):229-32. PubMed ID: 7798670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Vannier E; van Dalen R; Pesman G; Bartelink AK; Dinarello CA; van der Meer JW
    Blood; 1997 Aug; 90(3):1101-8. PubMed ID: 9242541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.
    Westendorp RG; Hottenga JJ; Slagboom PE
    Lancet; 1999 Aug; 354(9178):561-3. PubMed ID: 10470701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.
    Sprong T; van der Ven-Jongekrijg J; Neeleman C; van der Meer JW; van Deuren M
    Crit Care Med; 2009 Oct; 37(10):2812-8. PubMed ID: 19707127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.